Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Bellerophon Therapeutics Q1 Earnings

Bellerophon Therapeutics (NASDAQ:BLPH) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bellerophon Therapeutics (NASDAQ:BLPH) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Bellerophon Therapeutics missed estimated earnings by 9.26%, reporting an EPS of $-0.59 versus an estimate of $-0.54.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 3.39% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Bellerophon Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: PCTEL Q2 Earnings

By Benzinga Insights
Today, 6:31 AM
Shares of PCTEL (NASDAQ:PCTI) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 36.36% year over year to $0.07, which beat the estimate of $0.06.

PCTI